Explore more publications!
Healthcare Times Denmark
Got News to Share?

Press Releases

Digital Health Monitoring Devices Market Size to Reach USD 35.12B by 2035 from USD 7.40B in 2026 (CAGR 18.90%)
10 hours ago

Digital Health Monitoring Devices Market Size to Reach USD 35.12B by 2035 from USD 7.40B in 2026 (CAGR 18.90%)

Indeterminate GlobeNewswire, Inc.
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
10 hours ago

Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations

Indeterminate GlobeNewswire, Inc.
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
12 hours ago

Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers

Indeterminate GlobeNewswire, Inc.
Health Experts Highlight 7 Reasons Seniors Should Stay Active
Apr. 13, 2026

Health Experts Highlight 7 Reasons Seniors Should Stay Active

Neutral EIN Presswire
Major Shareholder Announcement
9 hours ago

Major Shareholder Announcement

Indeterminate GlobeNewswire, Inc.
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
14 hours ago

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026

Indeterminate GlobeNewswire, Inc.
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
Jan. 1, 1970

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq

Indeterminate GlobeNewswire, Inc.
ESO Acquires d2i, Accelerating Emergency Intelligence to Drive Performance and Improve Outcomes across Fire, EMS and Health Systems
Jan. 1, 1970

ESO Acquires d2i, Accelerating Emergency Intelligence to Drive Performance and Improve Outcomes across Fire, EMS and Health Systems

Indeterminate GlobeNewswire, Inc.
Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks
Jan. 1, 1970

Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks

Indeterminate MENAFN
Owner: Sawsan Dababneh

MENAFN

Indeterminate
Owned By Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Jordan, Amman
Owner Country Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035
Mar. 31, 2026

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035

Neutral EIN Presswire
Dutch Nonprofit Files Lawsuit Against Meta for Child Mental Health Risks
Jan. 1, 1970

Dutch Nonprofit Files Lawsuit Against Meta for Child Mental Health Risks

Indeterminate MENAFN
Owner: Sawsan Dababneh

MENAFN

Indeterminate
Owned By Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Jordan, Amman
Owner Country Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Total number of shares and voting rights in Zealand Pharma as of March 31, 2026
Jan. 1, 1970

Total number of shares and voting rights in Zealand Pharma as of March 31, 2026

Indeterminate GlobeNewswire, Inc.
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
Jan. 1, 1970

MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire, Inc.
Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula
Jan. 1, 1970

Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula

Indeterminate GlobeNewswire, Inc.
2026 Global PassportRanking Top 10: Why Traditional Visa-Free Leaders Are Falling Behind
11 hours ago

2026 Global PassportRanking Top 10: Why Traditional Visa-Free Leaders Are Falling Behind

Neutral EIN Presswire
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer
Mar. 17, 2026

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer

Neutral EIN Presswire
Resolutions from Zealand Pharma's Annual General Meeting 2026
Jan. 1, 1970

Resolutions from Zealand Pharma's Annual General Meeting 2026

Indeterminate GlobeNewswire, Inc.
Older Adults Health Supplements Market to Reach USD 351.1 Billion by 2036 Amid Rising Global Ageing Demand
Mar. 26, 2026

Older Adults Health Supplements Market to Reach USD 351.1 Billion by 2036 Amid Rising Global Ageing Demand

Neutral EIN Presswire
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
Jan. 1, 1970

VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management

Indeterminate GlobeNewswire, Inc.
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
Jan. 1, 1970

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions